Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

3.6K
A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
3.6K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Prone-Transpsoas Approach for Single-Position Lateral Corpectomy: A Case Series.

Brain sciences·2026
Same author

Evaluating the Use of Large Language Models in Improving the Readability of Online Patient Education Materials for Peripheral Nerve Surgery.

Healthcare (Basel, Switzerland)·2026
Same author

Glioma-intrinsic MAPK/ERK signaling promotes immunotherapy efficacy through T cell infiltration and interferon responses.

Nature communications·2026
Same author

The Value of SSTR PET for Detection, Definition, and Ongoing Management of Meningioma.

Radiology·2026
Same author

Standard work tools for managing pediatric baclofen pump infections and withdrawal.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2026
Same author

Surgeon Experience and Patient Outcomes in Spine Surgery: A Narrative Review of Tenure, Volume, and Performance.

JBJS reviews·2026
Same journal

Precision Proteomic Profiling of Systemic Lupus Erythematosus-Correlating Disease Activity and Complement Levels with Clinical Phenotypes.

Biomedicines·2026
Same journal

The Role of Salivary Microbiota in Pancreatic Cancer: From Screening to Tumor Progression and Treatment Response.

Biomedicines·2026
Same journal

Diagnostic Utility of Surface Electromyography for Identifying Muscles Affected by Myofascial Trigger Points: A Scoping Review.

Biomedicines·2026
Same journal

Performance Assessment of a Locally Semi-Automated NGS-Based Workflow for Homologous Recombination Deficiency Testing in High-Grade Serous Ovarian Carcinoma.

Biomedicines·2026
Same journal

Coupling and Uncoupling Pleiotropy Between Hypertension and Type 2 Diabetes Contribute to Exploring Potential Heterogeneity in Cardiovascular Risk in East Asian Population.

Biomedicines·2026
Same journal

Maternal Response to Therapeutic Plasma Exchange in Early Gestation: A Case Series of Thrombotic Microangiopathies and Neurological Disorders.

Biomedicines·2026
See all related articles

Related Experiment Video

Updated: Sep 10, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.6K

Transcriptomic Comparisons of Somatic and Cancer Stem Cells.

Austin Drysch1, Arun Ahuja1, Dillan Prasad1

  • 1Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

Biomedicines
|August 28, 2025
PubMed
Summary
This summary is machine-generated.

Cancer stem cells (CSCs) hijack normal stem cell pathways, driving tumor growth and resistance. Understanding transcriptomic and epigenetic differences between CSCs and somatic stem cells (SSCs) is key for targeted cancer therapies.

Keywords:
cancer stem cellsprecision medicineregenerative medicinesignaling pathwayssomatic stem cellsstemnesstranscriptomicstumor microenvironment

More Related Videos

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays
08:39

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays

Published on: January 3, 2015

9.7K
Analysis of Side Population in Solid Tumor Cell Lines
06:26

Analysis of Side Population in Solid Tumor Cell Lines

Published on: February 23, 2021

4.5K

Related Experiment Videos

Last Updated: Sep 10, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.6K
Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays
08:39

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays

Published on: January 3, 2015

9.7K
Analysis of Side Population in Solid Tumor Cell Lines
06:26

Analysis of Side Population in Solid Tumor Cell Lines

Published on: February 23, 2021

4.5K

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Molecular Biology

Background:

  • Stem cells are crucial for tissue repair, but their dysregulation leads to cancer stem cells (CSCs).
  • CSCs drive tumor progression, metastasis, and resistance to therapy.
  • A gap exists in understanding transcriptomic differences between normal somatic stem cells (SSCs) and CSCs.

Purpose of the Study:

  • To synthesize current knowledge on stemness regulation in SSCs and CSCs.
  • To highlight the divergence in transcriptomic landscapes between SSCs and CSCs.
  • To provide a framework for developing targeted therapies against CSCs.

Main Methods:

  • Review of key signaling pathways (Wnt, Notch, Hedgehog, TGF-β).
  • Analysis of transcription factors (Oct4, Sox2, Nanog, c-Myc, YAP/TAZ).
  • Examination of epigenetic mechanisms (chromatin remodeling, DNA methylation, microRNA).

Main Results:

  • Identified key pathways, transcription factors, and epigenetic mechanisms governing stemness.
  • Highlighted the role of EMT, cellular plasticity, and microenvironment in CSC phenotypes.
  • Emphasized context-specific pathway modulation distinguishing regeneration from tumorigenesis.

Conclusions:

  • Understanding transcriptomic and epigenetic differences is crucial for CSC-specific vulnerabilities.
  • Targeted therapies can be developed to eliminate CSCs while preserving normal stem cell function.
  • This knowledge advances precision oncology and minimizes damage to healthy tissues.